Nika Pharmaceuticals, Inc. (NIKA)

OTCMKTS · Delayed Price · Currency is USD
0.756
+0.367 (94.72%)
At close: Feb 13, 2026
-24.45%
Market Cap 791.42M
Revenue (ttm) n/a
Net Income (ttm) -51.76K
Shares Out 1.05B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 159
Average Volume 7,432
Open 0.756
Previous Close 0.388
Day's Range 0.756 - 0.756
52-Week Range 0.250 - 0.957
Beta -1.61
RSI 60.77
Earnings Date Mar 27, 2026

About Nika Pharmaceuticals

Nika Pharmaceuticals, Inc., a pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases. It offers dietary supplements and antiviral drugs, as well as thymus nuclear glycoprotein for the treatment of HIV. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada. [Read more]

Sector Healthcare
Founded 2000
Country United States
Stock Exchange OTCMKTS
Ticker Symbol NIKA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.